Epidemiology and Intervention of Obstructive Sleep Apnea Based on Community
Study Details
Study Description
Brief Summary
This observational study in a real-world community was designed to perform epidemiological investigation and assess effect of CPAP intervention of obstructive sleep apnea.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Patients with obstructive sleep apnea receiving CPAP or not would be observed in years. Primarily Impact of CPAP on health assessment andx control rate of hypertension would evaluated.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
CPAP group Automatic Continuous Positive Airway Pressure treatment and usual care |
Device: Auto-CPAP
Automatic Continuous Positive Airway Pressure treatment is the first-line treatment of obstructive sleep apnea
|
Usual care group Usual care without Continuous Positive Airway Pressure treatment |
Outcome Measures
Primary Outcome Measures
- Health assessment [From 1st Aug 2017 to 31st Dec 2020]
Health assessment would be performed by 36-Item Short-Form Health Survey.
- Sleep quality [From 1st Aug 2017 to 31st Dec 2020]
Sleep quality would be performed by Pittsburgh Sleep Quality Index.
- Psychological assessment [From 1st Aug 2017 to 31st Dec 2020]
Psychological assessment would be performed by Hospital Anxiety and Depression Scale.
- Control rate of hypertension [From 1st Aug 2017 to 31st Dec 2020]
Secondary Outcome Measures
- Incidence of chronic diseases [From 1st Aug 2017 to 31st Dec 2025]
Chronic diseases include hypertension, coronary heart disease, stroke and diabetes.
- Death from all-cause [From 1st Aug 2017 to 31st Dec 2025]
- Medical cost [From 1st Aug 2017 to 31st Dec 2025]
Medical fee, annually time of outpatient visit and hospitalization
Eligibility Criteria
Criteria
Inclusion Criteria:
- AHI >= 5 events/h
Exclusion Criteria:
-
Any condition which in the opinion of researched makes the eligible participants unsuitable for this study, such as severe COPD, heart failure in NYHA class III to IV, and others
-
Any condition potentially precluding follow-up visits, such as sereve insomnia, cognitive behavioral disorder, and others
-
Patients receiving CPAP treatment
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Community of Huanghua Road | Guangzhou | China | 510000 |
Sponsors and Collaborators
- Guangdong Provincial People's Hospital
Investigators
- Principal Investigator: Qiong Ou, M.D., Guangdong Provincial People's Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- GDREC2016275H(R1)